Global Cord Blood Corporation

Global Cord Blood Corporation

$2.99
0 (0%)
New York Stock Exchange
USD, HK
Medical - Diagnostics & Research

CO Price Chart

Basic
Market Cap$400.08M
Price$2.99
52 Week Range0.6001-3.59
Beta-0.04
Margins
Gross Profit Margin85.26%
Operating Profit Margin48.97%
Net Profit Margin40.30%
Valuation (TTM)
P/E Ratio1.78
Price to Sales Ratio0.79
Price to Book Ratio0.18
PEG Ratio0.02

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Full-Time Employees

1,202

IPO Date

2007-01-25T00:00:00.000Z

Description

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Phone

852 3605 8180

Address

Bank of China Tower, Central, HK

CIK

0001467808